glp-1 compounding news november 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines Compounded GLP-1 Drugs and its

The use of buthionine sulfoximine, which inhibits gamma-glutamylcysteine synthetase, has been investigated in animals as a method to decrease GSH

Weis, F

Transgenic mice in which GCLC expression is abolished in hepatocytes have 58% of normal hepatic GSH levels and manifest liver pathologies characteristic of the various clinical stages of fatty liver disease 8,9

Important: Compounded semaglutide and compounded tirzepatide are not FDA approved

More importantly though, when I think about the drivers of the issuance, that I think in some ways is a little more validating

She also wonders whether the drugs effects will persist after dosing is complete